Business / Finance

RSS

Cigna posts strong revenue growth in third quarter 2013

Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.

31 Oct 2013

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma Inc. today reported results for the first quarter of its fiscal year ending June 30, 2014.

31 Oct 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.

31 Oct 2013

Novaquest closes $459 million private equity fund

NovaQuest Capital Management, L.L.C. is pleased to announce the final closing of NovaQuest Pharma Opportunities Fund III, L.P., a $459 million private equity fund focused on providing structured finance solutions to biopharmaceutical companies ("Fund III").

31 Oct 2013

Mylan's revenues decrease 2% to $1.77B in third quarter 2013

Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.

31 Oct 2013

Viropharma announces financial results for third quarter 2013

ViroPharma Incorporated reported today its financial results for the third quarter ended September 30, 2013. Net sales were $113 million for the third quarter ended September 30, 2013, as compared to $91 million in the same three months of 2012.

31 Oct 2013

Lifestyle Lift, Alliance Data sign multi-year agreement

Alliance Data Systems Corporation, a leading provider of loyalty and marketing solutions derived from transaction-rich data, today announced its Retail Services business has signed a multi-year agreement to provide private label credit card services for Lifestyle Lift (www.lifestylelift.com), further extending Alliance Data's presence in the elective medical and cosmetic procedure segment.

31 Oct 2013

MEDNAX reports revenue growth of 17.3% to $555M

MEDNAX, Inc., the national medical group specializing in neonatal, maternal-fetal, pediatric cardiology, other pediatric subspecialties and anesthesia physician services, today reported earnings of $1.52 per share for the three months ended September 30, 2013 resulting from strong revenue growth, primarily from recent acquisitions.

31 Oct 2013

Hemp shareholders set to receive additional stock in Bioadaptives

Hemp, Inc., shareholders are set to receive additional stock in BioAdaptives, Inc. Executives of Hemp, Inc. solidified the all-stock deal with BioAdaptives, Inc. by selling the assets of its subsidiary, BioSwan, Inc. on October 25, 2013.

31 Oct 2013

Alkermes reports 38% of year-over-year revenue growth from key products

Alkermes plc today reported financial results for the quarter ended Sept. 30, 2013. This is the second quarter of the nine-month period ending Dec. 31, 2013, as the company transitions to reporting on a calendar year basis.

31 Oct 2013

Nanosonics named healthcare industry’s Company of the Year for 2013

Nanosonics Limited (ASX: NAN) is pleased to announce it has been named the healthcare industry’s Company of the Year for 2013.

31 Oct 2013

Teleflex net revenues increase 12.4% to $413.8 million in third quarter 2013

Teleflex Incorporated today announced financial results for the third quarter ended September 29, 2013.

30 Oct 2013

MiMedx Group reports record revenue in third quarter 2013

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

30 Oct 2013

Immune Design closes Series C financing totalling up to $49M

Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced it has closed a Series C financing totalling up to $49 million.

30 Oct 2013

Cvrx closes additional $12 million under its Series F financing

CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing. This brings the total raised in the Series F financing to $42 million.

30 Oct 2013

USCB acquires ReMed Recovery Care Centers

US Community Behavioral, LLC ("USCB"), a leading multi-state provider of community-based residential and behavioral services, announced it has acquired ReMed Recovery Care Centers, LLC, a highly regarded provider of brain injury rehabilitation services based in Pennsylvania.

30 Oct 2013

Wiley expands partnership with EMBO

John Wiley & Sons, Inc., today announced that it will provide editorial production, global marketing and distribution services for The EMBO Journal, EMBO reports and Molecular Systems Biology. This expanded partnership with EMBO adds three leading scientific journals alongside EMBO Molecular Medicine, which Wiley has published since 2009.

30 Oct 2013